$70.34 (+3.17%) | As of Aug-29-2025, 4:10 PM ET 🧪💸

🚨 Trigger: Insider Chemistry Lab Is Open

Not one, not two, but practically the whole executive lab team just bought stock test tubes worth of EMN. CEO ✔️ CFO ✔️ Board of Directors ✔️ EVPs ✔️ It’s a shareholder chemistry set gone wild.

• CEO Mark Costa: +7,400 shares = +$502K

• CFO McLain: +3,670 shares = +$252K

• Nine other execs/directors: all in for hundreds of thousands

That’s close to a dozen officers stirring the insider pot. When the chemists themselves drink their own potion… you know something’s brewing. 🧪➡️📈

🏛 Institutions Join the Lab Club

Institutions own 92% of the float. Vanguard, BlackRock, State Street—check. Dimensional, Invesco, Franklin—check.
Wall Street basically owns the beakers, the burners, and maybe the safety goggles too.

For Eastman Chemical (EMN)'s Institutional Ownership breakdown, 🔍 see here

🏭 Business Profile: What Do They Actually Do?

Eastman isn’t trying to reinvent the chip or colonize Mars. Instead, it’s about specialty materials you use daily without even noticing.

• Additives & Functional Products: surfactants, solvents, aviation fluids, paint enhancers 🎨✈️

• Advanced Materials: fancy plastics, films, and biopolymers for cars, electronics, and medical gear 🚗💻🩺

• Chemical Intermediates: olefins, acetyl derivatives, solvents (aka the industrial glue of the world) 🏭

• Fibers: cellulose acetate tow (cigarette filters, specialty fibers, even aerospace!) 🚬✈️

In short: it’s the chemistry behind your lipstick, your iPhone screen protector, your car dashboard, and—yes—your cigarette filter. 🔬

📉 Latest Results: A Bit of a Burn

Q2 2025 was a lab mishap:

• Revenue: $2.29B (down from $2.36B)

• Adjusted EPS: $1.60 (down from $2.15)

• Cash Flow: $233M (down from $367M)

Tariffs, weak demand, and even an unplanned outage (oops, the beaker cracked) hit the bottom line.

But—Additives & Functional Products actually grew +7%. Heat transfer fluids & care chemicals are still strong. Advanced Materials is holding up despite weak auto/construction markets.

👉 Want the full picture? Dive into Eastman Chemical (EMN)'s financials here.

📊 Valuation: Cheap Chemistry?

• P/E: 9.59 (was ~15 a year ago)

• Price/Sales: 0.86

• EV/EBITDA: 7.4

• Dividend Yield: ~4.9%

Translation: This is value-investor catnip. 🐭

Add in $700M returned to shareholders in 2024 (dividends + buybacks), and EMN is still a shareholder-friendly chem lab.

⚠️ Risks: Handle with Gloves

• Tariffs + global macro mess = volatile demand

• Commodities can blow up margins

• Stock already halved since 2021 highs ($130 → $70)

• If humanity goes extinct, your EMN shares won’t help. (But hey, insider buying suggests we’re safe for now 🤷)

💡💡💡 Curious about another deep oil exploration play?
Check our takes on UnitedHealth Group or even Oscar Health.

💡 Verdict

This is one of those moments where management + institutions + valuation align. Insiders are all-in, institutions are holding steady, and the stock trades at bargain-bin multiples.

Chemistry is risky, sure—but so is dating on Tinder. At least EMN pays you 5% while you wait. 💘🧪

⚠️ Disclaimer:

We love good chemistry but we’re not chemists. Invest at your own risk—including hazards like fires, explosions, and bad puns—always DYOR, hold the FOMO, and don’t invest what you can’t afford to lose.
We laugh, we analyze, we meme. We sell jokes and opinions — and yes, we’re billing your sense of humor. 🎪💸 
We’re not financial advisors. We’re FUNancial advisors. 

🧭 Want More Like This?

• 🕵️ Insider Purchases Center
• 📣 Follow the Pundits Hub
• 📈 Young Guns & Turnaround Stocks — Track More Growth (and Growing-Pain) Plays
• 😆 Stock Market Humor & Serious-ish Plays
• 🌍 See the world differently and check out more international market picks and fun takes. Explore International Investment Opportunities and value plays 💸 Cheap Stocks with (Maybe) Big Upside
• 🧟 Corporate Resurrection Series — Our special series on companies rising from the financial grave. 🎯 The “Turnaround or Toast” Series (If it still exists. We’re not sure. Ask the intern.)
• 📈 Biotech Bets & Innovation Radar (Problem is we can't detect the Radar)

😂 Laugh, Learn, Invest: funanc1al.com | Funanc1al: Where Even Finance Meets Funny